CMLE OKed to start commercial API production at Netherlands plant
Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.
Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.
The human tissue supply industry is under pressure from CROs demanding more complex samples, according to equity analyst Vadim Alexandre.
Peptide-based therapeutics specialists Unigene will focus on high valuation drug development and drug delivery opportunities after cutting loose its Site Directed Bone Growth (SDBG) patent portfolio.
Clinical trial enrollment can be accelerated by better understanding patients and using EHRs to inform protocol design, panelists told an Outsourcing-Pharma conference.
Big pharma companies looking to invest in 'superbug' R&D could soon see a better return through Altermune Technologies' new platform.